US Patent 10183928 Inhibitors of RET
Patent 10183928 was granted and assigned to Blueprint Medicines on January, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 17, 2017
0
Date of Patent
January 22, 2019
0
Patent Applicant
Patent Application Number
15462255
0
Patent Citations Received
Patent Inventor Names
Jason D. Brubaker
0
Joseph L. Kim
0
Kevin J. Wilson
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10183928 Inhibitors of RET
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
